Reason for request
Extension of indication
Clinical Benefit
| Substantial |
Substantial in type 1 diabetes in children aged 2 to 5 years. |
Clinical Added Value
| no clinical added value |
LANTUS provides no improvement in actual benefit (IAB V, non-existent) in the management of children aged 2 to 5 years with type 1 diabetes. |
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
FwvLnQSQ6qcyKvcT
